Atypical femur fractures associated with bisphosphonates: from prodrome to resolution


Submitted: 8 June 2015
Accepted: 22 July 2015
Published: 20 October 2015
Abstract Views: 1460
PDF: 733
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Atypical fractures related to the prolonged use of bisphosphonates are caused by low energy mechanisms and are characterized by oblique and transverse lines and frequent bilateralism. We present a clinical case of a patient who we believe illustrates, both in clinical and radiological aspects, the new definition of atypical femur fracture related to treatment using bisphosphonates treated conservatively and successfully with discharge and teriparatide 20 mcg/80 mcl s.c./24h. The appearance of painful symptoms in the upper thigh, especially if bilateral, in patients treated with bisphosphonates for long periods of time, makes it necessary to dismiss bone lesions that might otherwise suggest atypical fracture. In those cases where the fracture is incomplete, restoring bone metabolism through the administration of teriparatide 20 mcg/80 mcl s.c./24h could prevent displaced fractures.

Supporting Agencies


Sastre-Jala, B., Heredia-Heredia, E., Franco-Ferrando, N., & Poquet-Jornet, J. (2015). Atypical femur fractures associated with bisphosphonates: from prodrome to resolution. Rheumatology Reports, 7(1). https://doi.org/10.4081/rr.2015.6068

Downloads

Download data is not yet available.

Citations